BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9191827)

  • 1. Prevalence of hepatitis G virus RNA in French blood donors and recipients.
    Loiseau P; Mariotti M; Corbi C; Ravera N; Girot R; Thauvin M; Portelette E; Mariette X; Roudot-Thoraval F; Benbunan M; Lefrère JJ
    Transfusion; 1997 Jun; 37(6):645-50. PubMed ID: 9191827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
    Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
    N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia.
    Poovorawan Y; Theamboonlers A; Chongsrisawat V; Seksarn P; Jarvis L; Simmonds P
    J Gastroenterol Hepatol; 1998 Mar; 13(3):253-6. PubMed ID: 9570237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated or nosocomial hepatitis G virus infection in patients undergoing surgery.
    Lunel F; Frangeul L; Chuteau C; Fretz C; Thiers V; Azar N; Bidet JM; Huraux JM; Bréchot C; Valla D; Opolon P
    Transfusion; 1998; 38(11-12):1097-103. PubMed ID: 9838943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission.
    Lefrère JJ; Roudot-Thoraval F; Morand-Joubert L; Brossard Y; Parnet-Mathieu F; Mariotti M; Agis F; Rouet G; Lerable J; Lefèvre G; Girot R; Loiseau P
    Transfusion; 1999 Jan; 39(1):83-94. PubMed ID: 9920171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan.
    Wang JT; Chen PJ; Liu DP; Sheu JC; Wang TH; Chen DS
    Transfusion; 1998 Mar; 38(3):290-5. PubMed ID: 9563410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France.
    Cantaloube JF; Gallian P; Biagini P; Attoui H; Escher J; Zappitelli JP; Delord Y; de Micco P; de Lamballerie X
    Transfusion; 1999 Jan; 39(1):95-102. PubMed ID: 9920172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
    Yoshikawa A; Fukuda S; Itoh K; Kosaki N; Suzuki T; Hirakawa K; Nakao H; Inoue T; Fukuda M; Okamoto H
    Transfusion; 1997 Jun; 37(6):657-63. PubMed ID: 9191829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
    Hitzler WE; Runkel S
    Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood.
    Sauleda S; Esteban JI; Hernandez JM; Reesink H; Castella D; Quer J; Hess G; Esteban R; Guardia J
    Transfusion; 1999 Jun; 39(6):633-8. PubMed ID: 10378844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors.
    Stark K; Meyer CG; Tacke M; Schwarz A; Braun C; Huzly D; Engel AM; May J; Bienzle U
    Transplantation; 1997 Aug; 64(4):608-12. PubMed ID: 9293874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis G virus in Queensland blood donors.
    Moaven LD; Hyland CA; Young IF; Bowden DS; McCaw R; Mison L; Locarnini SA
    Med J Aust; 1996 Oct; 165(7):369-71. PubMed ID: 8890843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients.
    Roth WK; Waschk D; Marx S; Tschauder S; Zeuzem S; Bialleck H; Weber H; Seifried E
    Transfusion; 1997 Jun; 37(6):651-6. PubMed ID: 9191828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis G virus and labile blood products: role of transfusional transmission].
    Merle P; Elghouzzi MH; Pradat P; Vidal F; Boiret E; Trépo C
    Transfus Clin Biol; 2004 Apr; 11(2):75-80. PubMed ID: 15120103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology.
    Lefrère JJ; Loiseau P; Maury J; Lasserre J; Mariotti M; Ravera N; Lerable J; Lefèvre G; Morand-Joubert L; Girot R
    Blood; 1997 Nov; 90(9):3776-80. PubMed ID: 9345065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis G virus infection in kidney transplant recipients.
    Dussol B; Charrel R; De Lamballerie X; Berthezene P; Brunet P; De Micco P; Raoult D; Berland Y
    Transplantation; 1997 Aug; 64(3):537-9. PubMed ID: 9275127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis.
    Ideura T; Tanaka E; Nakatsuji Y; Kobayashi M; Kanno Y; Oguchi H; Hora K
    J Gastroenterol Hepatol; 1997 Nov; 12(11):762-5. PubMed ID: 9430044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis G virus infection in acute fulminant hepatitis: prevalence of HGV infection and sequence analysis of a specific viral strain.
    Sheng L; Soumillion A; Beckers N; Wu CG; Verslype C; Nevens F; Pirenne J; Aerts R; Kosala H; Fevery J; Yap SH
    J Viral Hepat; 1998 Sep; 5(5):301-6. PubMed ID: 9795913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical features of hepatitis G virus infection in bone marrow allograft recipients.
    Corbi C; Traineau R; Esperou H; Ravera N; Portelette E; Benbunan M; Gluckman E; Loiseau P
    Bone Marrow Transplant; 1997 Dec; 20(11):965-8. PubMed ID: 9422476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.